Breast cancer (BC) is the most prevalent malignancy among women worldwide, with the highest proportion being hormone receptor-positive (HR + ) human epidermal growth factor 2-negative (HER2-), accounting for approximately 70% of all cases [1]. This evidence concerns the gene ERBB2 and breast cancer.